Sandoz enters into agreement with Bio-Thera Solutions for Bevacizumab
Bevacizumab is a recombinant humanised monoclonal IgG1 antibody that targets vascular endothelial growth factor (VEGF), a key…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.